Viewing Study NCT02605356


Ignite Creation Date: 2025-12-24 @ 11:18 PM
Ignite Modification Date: 2026-01-03 @ 9:58 PM
Study NCT ID: NCT02605356
Status: WITHDRAWN
Last Update Posted: 2016-10-07
First Post: 2015-11-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 1b/2 Study Testing Radium-223 Dichloride/Bortezomib/Dexamethasone Combination in Relapsed Multiple Myeloma
Sponsor: Bayer
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module